Endoluxe, Mayo Clinic partner on AI research

Imaging company Endoluxe has entered into a know-how agreement with Rochester, Minn.- based Mayo Clinic to research the uses of artificial intelligence and machine learning in the treatment of bladder cancer.

Advertisement

Through the agreement, Mayo Clinic will use the Endoluxe Visualization System, a tool that utilizes AI to provide clinicians with data during surgical procedures, and in turn Endoluxe will use the insights gained to advance development of its platform, according to a Dec. 5 Endoluxe news release. 

Endoluxe designs its video platforms to be vendor agnostic.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.